Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 345.86M | 347.49M | 349.11M | 352.76M | 356.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 345.86M | 347.49M | 349.11M | 352.76M | 356.40M |
| Cost of Revenue | 135.14M | 133.79M | 132.43M | 134.65M | 136.86M |
| Gross Profit | 210.72M | 213.70M | 216.68M | 218.11M | 219.54M |
| SG&A Expenses | 165.80M | 165.44M | 165.09M | 165.09M | 165.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.12M | 7.55M | 7.98M | 6.96M | 5.95M |
| Total Operating Expenses | 323.98M | 322.71M | 321.44M | 323.14M | 324.84M |
| Operating Income | 21.88M | 24.78M | 27.68M | 29.62M | 31.57M |
| Income Before Tax | 29.61M | 31.08M | 32.54M | 31.83M | 31.12M |
| Income Tax Expenses | 5.06M | 4.42M | 3.78M | 3.79M | 3.80M |
| Earnings from Continuing Operations | 24.55 | 26.66 | 28.77 | 28.04 | 27.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.95M | -3.80M | -3.64M | -3.70M | -3.77M |
| Net Income | 20.60M | 22.86M | 25.13M | 24.34M | 23.55M |
| EBIT | 21.88M | 24.78M | 27.68M | 29.62M | 31.57M |
| EBITDA | 33.03M | 35.97M | 38.91M | 40.80M | 42.68M |
| EPS Basic | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 |
| Normalized Basic EPS | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| EPS Diluted | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 |
| Normalized Diluted EPS | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Average Basic Shares Outstanding | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B |
| Average Diluted Shares Outstanding | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 45.87% | 41.33% | 37.61% | 41.00% | 44.62% |